State and local leaders are betting billions of dollars in subsidies, tax breaks, loans and grants to biotech capitalists in the hopes of cashing in on a worldwide bio-boom.
But the industry’s volatility has some worried that taxpayer dollars are being gambled on a dangerous roll of the dice.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.